21st Annual Cardiometabolic Health Congress: Weaving a Tapestry of Prevention, Innovation, and Care in Cardiometabolic Health
October 15-17, 2026 at the Hilton Boston Park Plaza, Boston, MA
For CME information on the October 14 Pre-Conference, click here.
The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.
Describe the connections between cardiometabolic risk factors and their collective influence on the progression of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
Analyze recent evidence and guidelines to enhance the prevention, screening, and management of patients with cardio-renal metabolic risk or established cardio-renal metabolic disease
Identify effective strategies for early detection and prevention of cardio-renal metabolic disease, including comprehensive risk factor assessment and lifestyle interventions
Design personalized treatment plans for patients with cardio-renal metabolic disease by integrating current and emerging pharmacotherapies, considering safety, efficacy, comorbidities, and patient preferences to improve outcomes
Summarize the latest advancements in cardio-renal metabolic therapies to remain informed on the evolving landscape of treatment options
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Cardiometabolic Health Congress (CMHC). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
*Estimated credit hours only and subject to change
Partners designates this live activity for a maximum of 18* AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 18* contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
Partners designates this continuing education activity for 18* contact hour(s) (1.8 CEUS) of the Accreditation Council for Pharmacy Education.
This program offers 18.5 CPEUs for dietitians.
There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact our event registration team at CMHCRegistration@informa.com.
Full credit claim information will be provided closer to the meeting date.
To streamline the process, you can create an account in advance with our CME provider, Partners for Advancing Clinical Education, where the evaluation will be hosted. Please SIGN UP here: https://cme.partnersed.com.
For Pharmacists: Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Credit will be submitted automatically to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Information on faculty disclosures will be availble before the meeting.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.